Radiotherapy Dose and Induction Chemotherapy Cycles Are Associated With Prognosis and Toxicity Risk: A Retrospective Study of 227 Patients With Unresectable Stage III Non-Small-Cell Lung Cancer

Radiotherapy Dose and Induction Chemotherapy Cycles Are Associated With Prognosis and Toxicity Risk: A Retrospective Study of 227 Patients With Unresectable Stage III Non-Small-Cell Lung Cancer

Objective: Concurrent chemoradiation (cCHRT) has been confirmed as the standard treatment for local advanced non-small-cell lung cancer (NSCLC). This study is to assess the appropriate timing of radiotherapy and cycles of induction chemotherapy for those patients. Methods: 227 inoperable stage III N...

Full description

Bibliographic Details
Main Authors: Liyao Chen, Yu Hou, Yaoxiong Xia, Li Chang, Xianmin Diao, Li Wang, Lan Li, Qing Long, Ying Liu, Yan Liu, Wenhui Li
Format: Article
Language:English
Published: SAGE Publishing 2020-10-01
Series:Technology in Cancer Research & Treatment
Online Access:https://doi.org/10.1177/1533033820951802

Similar Items

Similar Items